Showing results (151-160 of 166) with videos related to

Sort By:
Pageof 17
Radiation Oncology (London, England)|June 15, 2019
Comparison of efficacy and safety between simultaneous integrated boost intensity-modulated radiotherapy and conventional intensity-modulated radiotherapy in locally advanced non-small-cell lung cancer: a retrospective studyDaquan Wang, Nan Bi, Tao Zhang, et al.
Signal Transduction and Targeted Therapy|October 15, 2025
Circulating tumor DNA refines consolidation immunotherapy for limited-stage small cell lung cancer patientsYin Yang, Yuqi Wu, Jingjing Zhao, et al.
European Journal of Haematology|April 12, 2011
Alkaline phosphatase variation during carfilzomib treatment is associated with best response in multiple myeloma patientsMaurizio Zangari, Monette Aujay, Fenghuang Zhan, et al.
Cancer Research|April 18, 2013
DNA methylation-mediated repression of miR-886-3p predicts poor outcome of human small cell lung cancerJianzhong Cao, Yongmei Song, Nan Bi, et al.
Oncotargets and Therapy|November 16, 2013
Nimotuzumab combined with radiotherapy for esophageal cancer: preliminary study of a Phase II clinical trialJun Liang, Mingyan E, Gang Wu, et al.
International Journal of Radiation Oncology, Biology, Physics|November 21, 2020
Erlotinib Versus Etoposide/Cisplatin With Radiation Therapy in Unresectable Stage III Epidermal Growth Factor Receptor Mutation-Positive Non-Small Cell Lung Cancer: A Multicenter, Randomized, Open-Label, Phase 2 TrialLigang Xing, Gang Wu, Luhua Wang, et al.
Journal of Hematology & Oncology|December 7, 2025
PACIFIC-5: a phase III clinical trial of consolidation durvalumab in patients with unresectable stage III NSCLC and no progression after concurrent or sequential chemoradiotherapyYi-Long Wu, Lin Wu, Nan Bi, et al.
Cancer Research|December 19, 2025
Cortactin Suppresses mTOR-Dependent Senescence in Circulating Tumor CellsJianyang Hu, Binyu Zhang, Junhao Chen, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 8, 2021
A validation study on the lung immune prognostic index for prognostic value in patients with locally advanced non-small cell lung cancerTao Zhang, Wenji Xue, Daquan Wang, et al.
Frontiers in Oncology|December 30, 2021
A Nomogram for Predicting Brain Metastasis in IIIA-N2 Non-Small Cell Lung Cancer After Complete Resection: A Competing Risk AnalysisShuang Sun, Yu Men, Jingjing Kang, et al.
Pageof 17